Intravenous and oral dosing of a direct-acting and...

Details Intravenous and oral dosing of a direct-acting and... Intravenous and oral dosing of a direct-acting and...

A - Human Necessities

61

K

A61K 31/216 (2006.01) A61K 31/517 (2006.01) A61P 7/02 (2006.01)

Patent

CA 2686203

The invention provides methods and compositions for rapid and reversible inhibition of platelet aggregation in human subjects in need thereof by administering compounds of the formula: (I) alone or in combination with a second agent which can be aspirin or a thrombolytic agent.

L'invention concerne des procédés et des compositions pour l'inhibition rapide et réversible de l'agrégation plaquettaire chez des sujets humains en ayant besoin par administration de composés de formule : (I) seuls ou en combinaison avec un second agent qui peut être de l'aspirine ou un agent thrombolytique.

Affiliated with

Also associated with

Rating

Intravenous and oral dosing of a direct-acting and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intravenous and oral dosing of a direct-acting and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intravenous and oral dosing of a direct-acting and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1900421